Home › Funds › Portolan Capital Management, LLC › BIIB
Portolan Capital Management, LLC position in BIIB
BIOGEN INC · Health Care
Portolan Capital Management, LLC reported holding 142,856 shares of BIIB (BIOGEN INC) in its Q2 2026 13F filing — a position valued at US$30.9M, representing 1.16% of its reported portfolio and ranking #24 among its reported holdings. Portolan Capital Management, LLC has disclosed BIIB holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Portolan Capital Management, LLC's BIIB position evolved
Portolan Capital Management, LLC first disclosed a stake in BIIB in Q4 2025 at 84,990 shares (US$15.0M). The position peaked in Q2 2026 at 142,856 shares, worth US$30.9M. Across 3 filings, Portolan Capital Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 142,856 shares valued at US$30.9M — an increase of 24,375 shares quarter over quarter.. Notable position changes include a 39% increase in Q1 2026 (shares rose 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 84.99K | $14.96M | New |
| Q1 2026 | 118.48K | $21.72M | Add |
| Q2 2026 | 142.86K | $30.87M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIIB and 13F data
BIIB (BIOGEN INC) is a Health Care company. 22 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIIB
- PRIMECAP MANAGEMENT CO/CA/ 15.15M sh · $3.27B · Q2 2026
More on Portolan Capital Management, LLC
FAQ
How long has Portolan Capital Management, LLC held BIIB?
Portolan Capital Management, LLC has disclosed BIIB holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Portolan Capital Management, LLC's current position in BIIB?
As of Q2 2026, Portolan Capital Management, LLC holds 142.86K shares of BIIB (BIOGEN INC), valued at $30.87M, representing 1.16% of its reported portfolio and ranking #24.
Has Portolan Capital Management, LLC been buying or selling BIIB?
In the latest 13F filing (Q2 2026), Portolan Capital Management, LLC increased its position in BIIB. The position peaked in Q2 2026 at 142.86K shares.
Which other funds hold BIIB?
Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.